Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03876288 · ClinicalTrials.gov registry record
Gastroparesis Outcome Longitudinal Database Enrolled Numerically
A clinical trial of Gastroparesis, sponsored by University of Louisville.
- Recruiting
- Registry status
- 3,000
- Enrollment target
- 1
- Study location
NCT03876288 is a study of Gastroparesis that is actively recruiting participants, run by University of Louisville. The registered enrollment target is 3,000 participants, above the 234-participant average among 44 other Gastroparesis trials with a reported enrollment target (1182% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03876288, a study of Gastroparesis, is actively recruiting participants, sponsored by University of Louisville.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 1
- Study location
Study Summary
GOLDEN is a longitudinal database of patients with the symptoms (Sx) of gastroparesis (Gp) who were seen and recorded at the University of Louisville from 2012 and is ongoing. Patients are enrolled and followed by sequential numbers and may include legacy patients seen at other centers by some of the same team and who are reported as part of the series. Outcome relate to patients Sx, survival, quality of life and other measures as detailed below, over time. The study tracks patients regardless of treatment but specifically focuses on GI Neuromodulation (gastric electrical stimulation - GES), Immunotherapy (IVIG), and Pyloric therapies (pyloroplasty, endoscopic). If treatments were administered GOLDEN allows for examination and stratification of outcome by groups both at baseline and at follow up.
Conditions Studied
Interventions
- DRUG Immunotherapy
- DEVICE GI Neuromodulation
- PROCEDURE Pyloric Therapies
Study Locations (1)
Kentucky
- University of Louisville - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2013-01-01 |
| Est. Completion | 2028-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03876288
The ClinicalTrials.gov registry entry for NCT03876288 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 234-participant average among 44 other Gastroparesis trials with a reported enrollment target (1182% higher). The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gastroparesis appearing as the primary indexed condition, and to 3 interventions - of which Immunotherapy is the first listed.
NCT03876288 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT03876288 about?
NCT03876288 is a clinical study titled "Gastroparesis Outcome Longitudinal Database Enrolled Numerically". GOLDEN is a longitudinal database of patients with the symptoms (Sx) of gastroparesis (Gp) who were seen and recorded at the University of Louisville from 2012 and is ongoing. Patients are enrolled and followed by sequential numbers and may include legacy patients seen at other centers by some of th...
What is the current status of trial NCT03876288?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2013-01-01. Estimated completion is 2028-01-01.
What conditions does trial NCT03876288 study?
This clinical trial studies the following conditions: Gastroparesis.
What interventions are being tested in trial NCT03876288?
The interventions under investigation include: Immunotherapy (DRUG), GI Neuromodulation (DEVICE), Pyloric Therapies (PROCEDURE).
Who is sponsoring clinical trial NCT03876288?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03876288 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroparesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gastroparesis Registry 4
RECRUITING
-
The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM
RECRUITING · NA
-
Study of Gastric Motility in Eosinophilic Gastritis
RECRUITING
-
Indiana University Gastrointestinal Motility Diagnosis Registry
RECRUITING
-
Compassionate Use of Domperidone for Refractory Gastroparesis
RECRUITING · NA
-
Central and Peripheral Effects of Cognitive Behavioral Therapy on Brain-Gut Axis Signaling in Gastroparetic Patients
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.